Reuters logo
BRIEF-Synairgen says AstraZeneca decided to stop phase IIa AZD9412 trial
October 12, 2016 / 6:51 AM / a year ago

BRIEF-Synairgen says AstraZeneca decided to stop phase IIa AZD9412 trial

Oct 12 (Reuters) - Synairgen Plc :

* AZD9412 clinical trial update

* Received Inexas clinical trial update from AstraZeneca relating to AZD9412

* AstraZeneca has decided to stop phase IIa trial for AZD9412 based on an interim analysis

* interim analysis showed an overall very low number of reported severe exacerbations that could make primary endpoint conclusions difficult

* AstraZeneca will evaluate key data collected from Inexas trial with a focus on secondary endpoints Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below